St. Francis Cancer Center | St. Francis Cancer Center | ADVL1622
st francis cancer center, cancer center greenville sc, cancer care greenville sc, aya cancer care, aya cancer care greenville sc
1842
clinical-trial-template-default,single,single-clinical-trial,postid-1842,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-3.2,wpb-js-composer js-comp-ver-4.12,vc_responsive

Clinical Trials

ADVL1622

ADVL1622 – Phase 2 Trial of XL184 (Cabozantinib), an Oral Small-Molecule Inhibitor of Multiple Kinases, in Children and Young Adults with Refractory Sarcomas, Wilms Tumor, and Other Rare Tumors…read more>

« Available Clinical Trials